Clover Health Investments
CLOV
162 hedge funds and large institutions have $484M invested in Clover Health Investments in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 52 increasing their positions, 30 reducing their positions, and 32 closing their positions.
73% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 30
49% more call options, than puts
Call options by funds: $37.3M | Put options by funds: $25M
44% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 32
9% more funds holding
Funds holding: 149 → 162 (+13)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
2.42% less ownership
Funds ownership: 41.82% → 39.4% (-2.4%)
38% less capital invested
Capital invested by funds: $782M → $484M (-$298M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$54.5M |
| 2 |
Two Sigma Investments
New York
|
+$40.5M |
| 3 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
+$32.5M |
| 4 |
Two Sigma Advisers
New York
|
+$26.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$18.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
Greenoaks Capital Partners
Orinda,
California
|
-$152M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.41M |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$1.82M |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$1.53M |
| 5 |
SC
Sculptor Capital
New York
|
-$1.43M |
CLOV Hedge Fund Activity: Q4 2021 in Review
162 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q4 2021, worth a combined $484M — down 38% from $782M a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new CLOV positions and 32 closed out — a net gain of 14 holders — while 52 added to existing stakes and 30 trimmed.
The largest buyer was Vanguard Group, adding an estimated $54.5M. The largest seller was Greenoaks Capital Partners, cutting an estimated $152M.
- 162 institutional investors held Clover Health Investments (CLOV) as of Q4 2021, up from 149 in Q3 2021.
- Funds reported $484M of Clover Health Investments stock for Q4 2021, down 38% quarter-over-quarter.
- 46 funds opened new Clover Health Investments positions in Q4 2021 and 32 closed out, a net change of +14 holders.
- The largest Clover Health Investments buyer in Q4 2021 was Vanguard Group, an estimated $54.5M added.
- The largest Clover Health Investments seller in Q4 2021 was Greenoaks Capital Partners, an estimated $152M sold.
Based on aggregated 13F filings for Q4 2021.